prikaz prve stranice dokumenta Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine
Access restricted to all Croatian higher education institution's students and staff
Scientific paper - Case study
Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine
British Journal of Dermatology, 186 (2021), 3; 110. https://doi.org/10.1111/bjd.20876
Žagar, Tina; Hlača, Nika; Brajac, Ines; Prpić‐Massari, Larisa; Peternel, Sandra; Kaštelan, Marija

Linked objects
COVID-19 | Virtual collection

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Žagar, T., Hlača, N., Brajac, I., Prpić‐Massari, L., Peternel, S. & Kaštelan, M. (2021). Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine. British Journal of Dermatology, 186. (3). doi: 10.1111/bjd.20876

Žagar, Tina, et al. "Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine." British Journal of Dermatology, vol. 186, no. 3, 2021. https://doi.org/10.1111/bjd.20876

Žagar, Tina, Nika Hlača, Ines Brajac, Larisa Prpić‐Massari, Sandra Peternel and Marija Kaštelan. "Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine." British Journal of Dermatology 186, no. 3 (2021). https://doi.org/10.1111/bjd.20876

Žagar, T., et al. (2021) 'Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine', British Journal of Dermatology, 186(3). doi: 10.1111/bjd.20876

Žagar T, Hlača N, Brajac I, Prpić‐Massari L, Peternel S, Kaštelan M. Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine. British Journal of Dermatology [Internet]. 2021 November 24 [cited 2024 April 18];186(3). doi: 10.1111/bjd.20876

T. Žagar, N. Hlača, I. Brajac, L. Prpić‐Massari, S. Peternel and M. Kaštelan, "Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine", British Journal of Dermatology, vol. 186, no. 3, November 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:079713. [Accessed: 18 April 2024]

Metadata
Title (english)Bullous Sweet syndrome following SARS‐CoV‐2 Oxford AstraZeneca vaccine
AuthorTina Žagar
AuthorNika Hlača
AuthorInes Brajac
AuthorLarisa Prpić‐Massari
AuthorSandra Peternel
AuthorMarija Kaštelan
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Dermatovenerology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Dermatovenerology
Languageenglish
Publication typeScientific paper - Case study
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleBritish Journal of Dermatology
Numberingvol. 186, no. 3, 110
p-ISSN0007-0963
e-ISSN1365-2133
DOIhttps://doi.org/10.1111/bjd.20876
URN:NBNurn:nbn:hr:184:079713
Publication2021-11-24
Document URLhttps://onlinelibrary.wiley.com/doi/10.1111/bjd.20876
Type of resourceText
Access conditionsRestricted access
Terms of useLicence In copyright icon
Created on2022-03-10 22:11:57